Send me a link:

*Text messaging rates may apply.

 Dow Down 1.72% Nasdaq Down 1.92%

Merrimack Pharmaceuticals, Inc. (MACK)

-NGM
5.94 Down 0.29(4.65%) 3:44PM EDT - Nasdaq Real Time Price
Prev Close:6.23
Open:6.12
Bid:5.93 x 3300
Ask:5.94 x 1300
1y Target Est:13.40
Beta:1.21
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.91 - 6.13
52wk Range:2.05 - 8.25
Volume:1,050,013
Avg Vol (3m):2,312,790
Market Cap:614.23M
P/E (ttm):N/A
EPS (ttm):-1.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for MACK

Comparison

Symbol% ChgMkt Cap
MACKDown 4.65%614.23M
IMMUDown 4.39%273.06M
LRUSFDown 1.46%61.09M
THLDDown 0.95%246.29M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.16
Quarterly EPS Est (Jun-14) :-0.30
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.91

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback